Jay H. Lefkowitch

14.4k total citations · 4 hit papers
141 papers, 8.6k citations indexed

About

Jay H. Lefkowitch is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Jay H. Lefkowitch has authored 141 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Epidemiology, 72 papers in Hepatology and 42 papers in Surgery. Recurrent topics in Jay H. Lefkowitch's work include Liver Disease Diagnosis and Treatment (63 papers), Liver Diseases and Immunity (28 papers) and Liver Disease and Transplantation (24 papers). Jay H. Lefkowitch is often cited by papers focused on Liver Disease Diagnosis and Treatment (63 papers), Liver Diseases and Immunity (28 papers) and Liver Disease and Transplantation (24 papers). Jay H. Lefkowitch collaborates with scholars based in United States, United Kingdom and Canada. Jay H. Lefkowitch's co-authors include Carlo H. Tamburro, Henry C. Bodenheimer, Karen L. Lindsay, Jules L. Dienstag, Ira M. Jacobson, Robert P. Perrillo, John A. Payne, Janice K. Albrecht, Alexandra L. Gibas and Carlton Meschievitz and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Biological Chemistry.

In The Last Decade

Jay H. Lefkowitch

136 papers receiving 8.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa

1989 1.4k citations Gary L. Davis, Eugene R. Schiff et al. profile →
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4

2012 999 citations Ali Mencin, Jay H. Lefkowitch et al. profile →
A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis B

1990 664 citations Robert P. Perrillo, Henry C. Bodenheimer et al. profile →
Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis

2016 313 citations Jay H. Lefkowitch et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Jay H. Lefkowitch	4.9k	4.4k	1.6k	1.4k	797	141	8.6k
Nobuyuki Enomoto	6.7k 1.3×	6.6k 1.5×	2.1k 1.3×	1.1k 0.8×	945 1.2×	308	11.6k
Graeme Alexander	7.2k 1.5×	7.2k 1.6×	1.3k 0.8×	1.6k 1.1×	711 0.9×	191	11.9k
Nizar N. Zein	6.6k 1.3×	5.1k 1.2×	922 0.6×	2.0k 1.4×	418 0.5×	179	9.4k
Shuhei Nishiguchi	5.4k 1.1×	5.3k 1.2×	1.2k 0.7×	1.1k 0.8×	711 0.9×	314	9.3k
Morikazu Onji	4.0k 0.8×	3.6k 0.8×	761 0.5×	1.1k 0.8×	639 0.8×	313	7.3k
Elwyn Elias	3.6k 0.7×	4.6k 1.0×	937 0.6×	3.0k 2.2×	1.2k 1.5×	229	8.5k
Thomas J. Layden	3.7k 0.7×	3.8k 0.8×	954 0.6×	816 0.6×	464 0.6×	119	6.5k
Tatsuo Kanda	3.4k 0.7×	3.4k 0.8×	1.8k 1.1×	1.1k 0.8×	879 1.1×	359	7.3k
Stephen Ryder	4.3k 0.9×	3.5k 0.8×	1.9k 1.2×	1.2k 0.9×	405 0.5×	199	7.6k
Paolo Geñtilini	5.3k 1.1×	6.9k 1.6×	1.4k 0.9×	2.4k 1.7×	851 1.1×	170	9.6k

Countries citing papers authored by Jay H. Lefkowitch

Since Specialization

Citations

This map shows the geographic impact of Jay H. Lefkowitch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay H. Lefkowitch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay H. Lefkowitch more than expected).

Fields of papers citing papers by Jay H. Lefkowitch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay H. Lefkowitch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay H. Lefkowitch. The network helps show where Jay H. Lefkowitch may publish in the future.

Co-authorship network of co-authors of Jay H. Lefkowitch

This figure shows the co-authorship network connecting the top 25 collaborators of Jay H. Lefkowitch. A scholar is included among the top collaborators of Jay H. Lefkowitch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay H. Lefkowitch. Jay H. Lefkowitch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Anna, et al.. (2021). Vibration-controlled Transient Elastography for Assessment of Liver Fibrosis at a USA Academic Medical Center. Journal of Clinical and Translational Hepatology. 10(2). 197–206. 14 indexed citations

Lagana, Stephen M., Satoru Kudose, Alina C. Iuga, et al.. (2020). Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data. Modern Pathology. 33(11). 2147–2155. 167 indexed citations

Marboe, Charles C., Jay H. Lefkowitch, Martina Pavlicová, et al.. (2019). Utility of 3D Printed Cardiac Models for Medical Student Education in Congenital Heart Disease: Across a Spectrum of Disease Severity. Pediatric Cardiology. 40(6). 1258–1265. 53 indexed citations

Fernandes, Danielle, Marcela Salomao, Alina C. Iuga, et al.. (2018). Pediatric Nonalcoholic Fatty Liver Disease in New York City: An Autopsy Study. The Journal of Pediatrics. 200. 174–180. 41 indexed citations

Lefkowitch, Jay H., et al.. (2017). Heart Disease and the Liver. Gastroenterology Clinics of North America. 46(2). 421–435. 37 indexed citations

Lagana, Stephen M., Susan J. Hsiao, Fei Bao, et al.. (2015). HepPar-1 and Arginase-1 Immunohistochemistry in Adenocarcinoma of the Small Intestine and Ampullary Region. Archives of Pathology & Laboratory Medicine. 139(6). 791–795. 11 indexed citations

Shin, Ji‐Yeon, Iván Méndez-López, Yuexia Wang, et al.. (2013). Lamina-Associated Polypeptide-1 Interacts with the Muscular Dystrophy Protein Emerin and Is Essential for Skeletal Muscle Maintenance. Developmental Cell. 26(6). 591–603. 74 indexed citations

Watanabe, Kazuhisa, Elizabeth Watson, María Laura Cremona, et al.. (2013). ILDR2: An Endoplasmic Reticulum Resident Molecule Mediating Hepatic Lipid Homeostasis. PLoS ONE. 8(6). e67234–e67234. 30 indexed citations

Verna, Elizabeth C., Rita M. Abdelmessih, Marcela Salomao, et al.. (2012). Cholestatic hepatitis C following liver transplantation: An outcome-based histological definition, clinical predictors, and prognosis. Liver Transplantation. 19(1). 78–88. 45 indexed citations

10.

Stravitz, R. Todd, Jay H. Lefkowitch, Robert J. Fontana, et al.. (2010). Autoimmune acute liver failure: Proposed clinical and histological criteria. Hepatology. 53(2). 517–526. 191 indexed citations

11.

Kadenhe‐Chiweshe, Angela V., Kimberly W. McCrudden, Jason S. Frischer, et al.. (2008). Sustained VEGF Blockade Results in Microenvironmental Sequestration of VEGF by Tumors and Persistent VEGF Receptor-2 Activation. Molecular Cancer Research. 6(1). 1–9. 64 indexed citations

12.

Vakiani, Efsevia, et al.. (2007). Hepatitis C–Associated Granulomas After Liver Transplantation. American Journal of Clinical Pathology. 127(1). 128–134. 8 indexed citations

13.

Cataldegirmen, Guellue, Shan Zeng, Nikki Feirt, et al.. (2005). RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-α and NF-κB. The Journal of Experimental Medicine. 201(3). 473–484. 115 indexed citations

14.

Lefkowitch, Jay H.. (2005). Morphology of Alcoholic Liver Disease. Clinics in Liver Disease. 9(1). 37–53. 144 indexed citations

15.

Schattenberg, Jörn M., Rajat Singh, Yongjun Wang, et al.. (2005). Jnk1 but not jnk2 promotes the development of steatohepatitis in mice†. Hepatology. 43(1). 163–172. 319 indexed citations

16.

Lefkowitch, Jay H.. (2005). Hepatobiliary pathology. Current Opinion in Gastroenterology. 21(3). 260–269. 2 indexed citations

17.

Lefkowitch, Jay H., et al.. (2002). Kupffer Cell Aggregation and Perivenular Distribution in Steatohepatitis. Modern Pathology. 15(7). 699–704. 84 indexed citations

18.

Bhagat, Govind, Steven Lobritto, Jay H. Lefkowitch, et al.. (2001). Allograft steatosis is a feature of progressive familial intrahepatic cholestasis, type 1 (FIC1 disease), treated by orthotopic liver transplantation (OLTX).. Hepatology. 34(4). 5 indexed citations

19.

Davis, Gary L., Eugene R. Schiff, Karen L. Lindsay, et al.. (1990). Treatment of chronic hepatitis C with recombinant α-interferon. A multicentre randomized, controlled trial. Journal of Hepatology. 11. S31–S35. 16 indexed citations

20.

Lefkowitch, Jay H., et al.. (1983). Hepatic fibrosis in fetal alcohol syndrome. Gastroenterology. 85(4). 951–957. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact